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Abstract
Aluminum and zinc have been related to the pathogenesis of Parkinson’s disease (PD), the former for its neurotoxicity and
the latter for its apparent antioxidant properties. 6-Hydroxydopamine (6-OHDA) is an important neurotoxin putatively
involved in the pathogenesis of PD, its neurotoxicity often being related to oxidative stress. The potential effect of these
metals on the oxidative stress induced by 6-OHDA autoxidation and the potential of ascorbic acid (AA), cysteine, and
glutathione to modify this effect were investigated. Both metals, particularly Al3, induced a significant reduction in cOH
production by 6-OHDA autoxidation. The combined action of AA and a metal caused a significant and sustained increase in
cOH generation, particularly with Al3, while the effect of sulfhydryl reductants was limited to only the first few minutes of
the reaction. However, both Al3 and Zn2 provoked a decrease in the lipid peroxidation induced by 6-OHDA autoxidation
using mitochondrial preparations from rat brain, assessed by TBARS formation. In the presence of AA, only Al3 induced a
significant reduction in lipid peroxidation. After intrastriatal injections of 6-OHDA in rats, tyrosine hydroxylase
immunohistochemistry revealed that Al3 reduces 6-OHDA-induced dopaminergic lesion in the striatum, which
corroborates the involvement of lipid peroxidation in 6-OHDA neurotoxicity and appears to discard the participation of
this mechanism on PD by Al3 accumulation. The previously reported antioxidant properties of Zn2 appear to be related to
the induction of Zn2-containing proteins and not to the metal per se. ß 2001 Elsevier Science B.V. All rights reserved.
Keywords: 6-Hydroxydopamine; Aluminum; Zinc; Antioxidant; Oxidative stress; Parkinson’s disease
1. Introduction
Parkinson’s disease (PD) is a late-onset, progres-
sive neurodegenerative disease, which is considered
the most frequent disorder of the basal ganglia.
The clinical characteristics are resting tremor, ri-
gidity, bradykinesia, and postural disturbance. These
motor abnormalities are associated with a speci¢c
loss of dopaminergic neurons in the substantia nigra
pars compacta and the subsequent depletion of dop-
amine levels in the striatum. The clinical manifesta-
tions of PD only appear when 70^80% of the men-
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tioned dopaminergic neurons are lost. Although sev-
eral molecular mechanisms have been proposed for
the pathogenesis of this disorder [1], the etiology of
PD remains unclear. However, there are increasing
data suggesting that oxidative stress may be involved
in the neuronal death which occurs in PD [2^4].
6-Hydroxydopamine (6-OHDA) is a neurotoxin
which, in the form of stereotaxic injections into the
medial forebrain bundle or substantia nigra, has been
used for years to produce a rodent model of PD [5].
More recently, a ‘partial lesion model’ has been de-
veloped which is particularly useful for research on
neuroprotection and neurotoxicity [6,7]. This model
is based on small intrastriatal injections of 6-OHDA
that produce the degeneration of nigrostriatal termi-
nals in a reduced striatal area, in which a drug-in-
duced increase or decrease of 6-OHDA derived le-
sion is easily detectable. Under physiological
conditions 6-OHDA su¡ers autoxidation by molecu-
lar oxygen to give a cascade of oxidative reactions
resulting in the formation of hydrogen peroxide
(H2O2) and an insoluble polymeric pigment related
to neuromelanin [8]. Although it has been reported
that 6-OHDA may act by inhibiting complex I of the
mitochondrial respiratory chain [9,10], its neurotox-
icity has often been linked to the production of free
radicals [11^13]. Evidently, it is possible that the
H2O2 resulting from the autoxidation of 6-OHDA
is easily reduced by the metal-catalyzed Fenton reac-
tion to generate the hydroxyl radical (cOH), which is
considered the most damaging free radical for living
cells.
Assuming the great ability of 6-OHDA to su¡er
autoxidation and produce cOH by a metal-catalyzed
reaction, the e¡ects of metals on this process would
seem particularly useful for a better understanding of
both the mechanism underlying the neurotoxicity of
6-OHDA and the suggested involvement of this neu-
rotoxin in the pathogenesis of PD [14,15]. Aluminum
(Al3) and zinc (Zn2) are two non-transition metal
ions which have often been related to the pathogen-
esis of PD [16^19], and several studies have shown
that Al3 is able to increase oxidative stress in both
rat brain [20,21] and cultured neurons [22]. In addi-
tion, it has also been suggested that the parkinson-
ism^dementia found on Guam Island is related to the
accumulation of Al3 in certain brain areas of the
patients su¡ering this disorder [23,24]. However, tak-
ing into account that Al3 is not a transition metal,
and hence cannot participate in redox reactions, the
molecular mechanism underlying this e¡ect remains
unclear [25]. Regarding Zn2, antioxidant properties
in relation to brain oxidative stress have been re-
ported [26^28]. Although it has been suggested that
these antioxidant properties may be related to the
capacity shown by Zn2 to induce the synthesis of
metallothionein [26], the precise mechanism of this
e¡ect is still unclear [28]. Furthermore, the complex-
ity of the physiological e¡ects of Zn2 is to be ex-
pected, given its proven ability to inhibit Ca2 trans-
port [29], induce neuronal apoptosis [30,31], inhibit
(Na,K)-ATPase [32] and provoke seizures [33].
Although it is well established that reductant sub-
stances may act as scavengers of free radicals, it is
also known that under certain conditions these sub-
stances may also display pro-oxidant properties.
Thus, although it has been reported that cOH pro-
duction by H2O2+Fe2 is enhanced by the presence
of ascorbic acid (AA), cysteine (CySH), and gluta-
thione (GSH) [34], it has also been found that GSH
is able to protect DNA from the oxidation caused by
H2O2+Fe2 [35]. Furthermore, it has recently been
reported that AA may enhance the neurotoxicity of
6-OHDA by inducing a redox cycle during 6-OHDA
autoxidation, while CySH and GSH protect against
the neurotoxicity of 6-OHDA [36]. For this reason, it
might be expected that the presence of these antiox-
idants could also a¡ect the potential e¡ects induced
by the assayed metal ions on the production of cOH
by 6-OHDA.
Thus, this study was undertaken to determine the
potential e¡ects of the presence of Al3 and Zn2 on
the generation of cOH during 6-OHDA autoxidation,
together with the role which certain antioxidant sub-
stances such as AA, CySH, and GSH might play. We
have also studied the e¡ect of the presence of these
metal ions on the lipid peroxidation induced by the
autoxidation of 6-OHDA in mitochondria prepara-
tions obtained from rat brain. Finally, the capacity
of Al3 to lesion, either by itself or in combination
with 6-OHDA, the nigrostriatal dopaminergic sys-
tem, was also investigated using a ‘partial lesion
model’ of PD in rats. Evidently, knowledge of the
molecular mechanisms underlying the action of po-
tential risk factors or neuroprotectors for PD may
lead to a better understanding of the pathogenesis
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of this disorder and might also help to develop new
strategies for its prevention.
2. Materials and methods
2.1. Chemicals
6-OHDA hydrobromide, AA, CySH, GSH, H2O2,
catalase (CAT), butylated hydroxytoluene crystalline,
deferoxamine mesylate, thiobarbituric acid, 1,1,3,3-
tetraethoxypropane, sodium dodecyl sulfate, Triton
X-100, 3,3P-diaminobenzidine, and bovine serum al-
bumin were obtained from Sigma (St. Louis, MO,
USA). Zinc chloride and ferrous chloride tetrahy-
drate were purchased from Fluka (Buchs, Switzer-
land). Aluminum chloride hexahydrate was obtained
from Riedel-de Hae«n (Seelze, Germany). Tereph-
thalic acid (THA) disodium salt was purchased
from Aldrich (Steinheim, Germany). Biotinylated
secondary antibody and avidin^biotin^peroxidase
complex were purchased from Vector (Burlingame,
CA, USA). Normal swine serum was obtained
from Dako (Glostrup, Denmark), and rabbit poly-
clonal antiserum to tyrosine hydroxylase (TH) from
Pel-Freez (Rogers, AK, USA). The water used for
the preparation of solutions was of Milli-RiOs/Q-
A10 grade (Millipore, Bedford, MA, USA). All re-
maining chemicals used were of analytical grade and
were from Fluka. Stock solutions of 6-OHDA were
prepared in 1.0 mM KCl (pH 2.0) to prevent its
autoxidation [37]. Fresh stock solutions of antioxi-
dants and metal ions were used, and prepared in
phosphate bu¡er (25 mM, pH 7.4) and water, respec-
tively. In order to prevent contamination by metal
ions, the contact of the di¡erent solutions used with
glassware was avoided as much as possible.
2.2. Mitochondria preparation
Male Sprague^Dawley rats weighing 200^250 g
were used. The rats were received from the breeder
at least 4 days before sacri¢ce, and were kept on a
12:12 light^dark schedule with ad libitum access to
food and water. Animals were stunned with carbon
dioxide and killed by decapitation. Brains were im-
mediately removed and washed in ice-cold isolation
medium (Na2PO4/KH2PO4 isotonized with sucrose,
pH 7.4). Brain mitochondria were then obtained by
di¡erential centrifugation with minor modi¢cations
to a previously published method [38]. Brie£y, after
removing blood vessels and pial membranes, the
brains were manually homogenized with 4 vols. (w/
v) of the isolation medium. The homogenate was
then centrifuged at 900Ug for 5 min at 4‡C, and
the supernatant centrifuged at 12 500Ug for 15
min. The mitochondria pellet was washed once
with isolation medium and recentrifuged under the
same conditions. Finally, the mitochondria pellet was
reconstituted in a bu¡er solution (Na2PO4/KH2PO4
isotonized with KCl, pH 7.4) and stored in aliquots
at 340‡C.
The protein concentration of mitochondria prepa-
rations was determined according to the method of
Markwell et al. [39], using bovine serum albumin as
the standard.
2.3. Production of cOH
The generation of cOH was £uorimetrically moni-
tored according to a modi¢cation made to a previ-
ously published method [40], in which THA is used
as a chemical dosimeter of cOH. A luminescence
spectrometer Model LS50B (Perkin-Elmer, Norwalk,
CT, USA) was used. The cuvette holder was thermo-
statically maintained at 37‡C and a magnetic stirrer
was used for continuous mixing of the sample. For
each assay, 2000 Wl of 25 mM phosphate bu¡er (pH
7.4) containing THA (10 mM) was incubated in a
quartz cuvette (optical path length 10 mm) for 5
min to reach the temperature. An aliquot of 25
mM phosphate bu¡er (pH 7.4) was added to take
the ¢nal volume of the incubation to 2.5 ml. Then,
20 Wl of metal (800 nM) and/or 100 Wl of antioxidant
(100 WM) and/or 20 Wl of a stock solution of 6-
OHDA (5 WM) were added. All concentrations are
¢nal concentrations in the incubation. The monitor-
ing of cOH formation was immediately initiated and
maintained for the subsequent 4 min, using 312 and
426 nm as excitation and emission wavelengths, re-
spectively. All £uorescence measurements were ex-
pressed relative to the initial reading.
2.4. Consumption of O2 and accumulation of H2O2
The O2 consumption during 6-OHDA autoxida-
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tion was monitored polarographically using a Clark-
type O2 electrode (Digital Oxygen System Model 10,
Rank Brothers, Cambridge, UK) equipped with a
device consisting of an ampli¢er, an A/D converter
(Model AD12, AM-Systems, Jae¤n, Spain) and the
corresponding software (LipSoft v. 2.0, AM-Sys-
tems) for data acquisition and control [41]. The elec-
trode was assembled in a 5 ml chamber surrounded
by a thermostatic water jacket set at 37‡C. A polar-
izing voltage of +0.60 V was used. For each assay,
2460 Wl 25 mM phosphate bu¡er (pH 7.4) or 2460 Wl
of this phosphate bu¡er containing antioxidant (8
mM) was incubated in the electrode chamber for 5
min in order to reach the temperature and the satu-
rating O2 concentration. Then, 20 Wl of metal ion (64
WM) and/or 20 Wl of 6-OHDA (400 WM) were in-
jected using a Hamilton syringe (Model 702SNR).
All concentrations are ¢nal concentrations in the in-
cubation. A magnetic agitator maintained the solu-
tion in the electrode chamber continuously under
vigorous stirring. The potential accumulation of
H2O2 was estimated from the production of O2 after
the injection of 2000 Wmol/min of CAT. For O2 elec-
trode calibration, the saturating O2 concentration
was taken as 237 WM and the zero was established
in the presence of sodium dithionite [42].
2.5. Evaluation of lipid peroxidation
Lipid peroxidation in mitochondria preparations
was assessed by spectrophotometric determination
of TBARS according to a modi¢cation made to a
previously published method [43] as follows. To
200 Wl of mitochondria preparation (1 mg protein/
ml), 25 Wl of Al3 or Zn2 (1.6 WM) or phosphate
bu¡er (pH 7.4) were added, followed by 25 Wl of 6-
OHDA (10 WM). In some experiments, 50 Wl of AA
(100 WM) were incorporated prior to the addition of
6-OHDA. The resulting mixture was incubated at
37‡C for exactly 10 min. Lipid peroxidation was
stopped by the addition of 25 Wl of butylated hydrox-
ytoluene (1 mM) and 25 Wl desferrioxamine (1 mM).
A volume of 750 Wl of acetic acid (20%) followed by
200 Wl of sodium dodecyl sulfate (8%, w/v) was
added and the mixture vortexed for 1 min. Then,
750 Wl of TBA (0.8%) were added and the resulting
mixture incubated at 95‡C for 60 min. After cooling
to room temperature, 3 ml of n-butanol were added
and the mixture shaken vigorously. After centrifuga-
tion at 4000 rpm for 5 min, the absorbance of the
supernatant (organic layer) was measured at 532 nm
using an Ultrospec III spectrophotometer (Pharma-
cia Biotech, Uppsala, Sweden). For calibration, a
standard curve (5^150 nM) was generated using the
malonodialdehyde derived by acid hydrolysis
(SO4H2 ; 1.5%, v/v) of 1,1,3,3-tetramethoxypropane
and the TBARS results expressed as nmol MDA/
mg protein.
2.6. Animal treatment
A total of nine male Sprague^Dawley rats (weigh-
ing about 200 g at the beginning of the experiments)
were used. All experiments were carried out in accor-
dance with the ‘Principles of laboratory animal care’
(NIH publication No. 86-23, revised 1985). All rats
received bilateral intrastriatal injections, and were di-
vided into two groups. Rats in group A (n = 4) were
injected with 2 Wl of sterile saline containing 0.48 Wg
of Al3 into the right striatum, and 2 Wl of sterile
saline into the left striatum. Rats in group B (n = 4)
were injected into the right striatum with 2 Wl of
sterile saline containing 0.48 Wg of Al3, and 10
min later with 6 Wg of 6-OHDA in 2 Wl sterile saline
containing 0.2% AA. Group B rats were injected into
the left striatum with 2 Wl of sterile saline, and 10
min later with 6 Wg of 6-OHDA in 2 Wl sterile saline
containing 0.2% AA. Stereotaxic coordinates were
1.0 mm anterior to bregma, 2.7 mm left or right of
midline, and 5.5 mm ventral to the dura; tooth bar
at 33.3. The solution was injected with a 5 Wl Ham-
ilton syringe at 0.2 Wl/min and the cannula was left in
situ for 5 min after injection. All surgery was per-
formed under equithesin anesthesia (3 ml/kg i.p.).
2.7. Immunohistochemistry
A week post lesion, the animals were deeply anes-
thetized with chloral hydrate and perfused ¢rst with
0.9% saline and then with cold 4% paraformaldehyde
in 0.1 M phosphate bu¡er, pH 7.4. The brains were
removed and subsequently washed and cryoprotected
in the same bu¡er containing 20% sucrose, and ¢-
nally cut on a freezing microtome. Sections were pro-
cessed by TH immunohistochemistry (as follows).
After incubation for 1 h in 10% normal swine serum
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with 0.25% Triton X-100 in 0.02 M potassium phos-
phate-bu¡ered saline containing 1% bovine serum
albumin (KPBS-BSA), sections were incubated over-
night at room temperature with rabbit polyclonal
antiserum to TH (1/500 in KPBS-BSA containing
2% normal swine serum and 0.25% Triton X-100).
The sections were subsequently incubated ¢rst for
90 min with the corresponding biotinylated second-
ary antibody (diluted 1/200) and then for 90 min
with an avidin^biotin^peroxidase complex. Finally,
the labeling was visualized with 0.04% hydrogen per-
oxide and 0.05% 3,3P-diaminobenzidine. TH immu-
nohistochemistry was quanti¢ed with the aid of
NIH-Image 1.55 image analysis software (Wayne
Rasband, MIMH) on a personal computer coupled
to a video camera (CCD-72, MTI). The lesioned area
surrounding the needle track on the left and right
striatum was evaluated using a constant illumination
light table (Northern Light, St. Catharines, Canada)
coupled to the video camera.
2.8. Statistical analysis
Data are expressed as the mean þ S.E.M. Di¡er-
ences between means were statistically evaluated us-
ing a two-sided Student’s t-test. The statistical signif-
icance of di¡erences in the rates of cOH production
in the presence of AA was assessed by testing the
slopes of the regression lines for parallelism using
the analysis of covariance (ANCOVA) [44]. Statisti-
cal di¡erences in dopaminergic lesions were tested
using one-way ANOVA followed by a post-hoc Tu-
key’s test. Normality of populations and homogene-
ity of variances were tested before each ANOVA.
The accepted level of signi¢cance in all cases was
P6 0.05.
3. Results
The formation of cOH during 6-OHDA autoxida-
tion was followed £uorimetrically and the maximum
value of the relative £uorescence (vFmax) after 4 min
of reaction was used to quantify the production of
cOH. As shown in Fig. 1, the autoxidation of 6-
OHDA (5 WM) caused an immediate generation of
cOH according to a hyperbolic kinetics. The O2 con-
sumption during the autoxidation of 6-OHDA was
followed polarographically and the H2O2 accumula-
tion was calculated from the polarographic recording
obtained with the addition of CAT (2000 units) after
216 s of reaction and taking into account the stoi-
chiometry of the reaction catalyzed by CAT. As il-
Fig. 1. E¡ects of the presence of Al3 on cOH formation during
6-OHDA autoxidation in the absence and presence of: (A) as-
corbic acid (AA), (B) L-cysteine (CySH), and (C) glutathione
(GSH). Incubations were carried out in 25 mM phosphate bu¡-
er (pH 7.5) at 37‡C. Concentration of reagents was as follows:
6-OHDA, 5 WM; Al3, 800 nM; antioxidant, 100 WM. cOH for-
mation is indicated by the detection of £uorescence using THA
as a chemical dosimeter.
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lustrated in Fig. 2, the autoxidation of 6-OHDA (400
WM) was accompanied by a signi¢cant consumption
of O2 and a considerable production of H2O2 (Fig.
2). Table 1 shows the corresponding values obtained
during the autoxidation of 6-OHDA (control values).
In order to achieve the best analytical response,
di¡erent concentrations of reagents were used in £u-
orimetric, polarographic, and spectrophotometric as-
says. However, the same relationship between con-
centrations was used in each analytical method for
statistical comparison of the results.
For a better understanding of the e¡ect of each
metal ion on cOH production by 6-OHDA autoxida-
tion in the presence of an antioxidant, we previously
studied the potential e¡ects of the assayed antioxi-
dants on the mentioned process. As shown in Fig.
1A, the autoxidation of 6-OHDA (5 WM) in the pres-
ence of AA (100 WM) caused a continuous produc-
tion of cOH, which continued for at least 30 min
(data not shown). In this case, the amount of cOH
generated involved an increase of 72% when com-
pared to the corresponding control value (Table 1).
A signi¢cant visual diminution in O2 consumption
and a signi¢cant reduction (342%) in H2O2 accumu-
lation were also observed during the autoxidation of
6-OHDA (400 WM) in the presence of AA (8 mM)
(Table 1). Although the presence of a sulfhydryl re-
ductant (CySH and GSH) also caused a signi¢cant
increase in the amount generated of cOH (+75% for
CySH and +143% for GSH), in this case the kinetics
of cOH production maintained its hyperbolic shape
(Fig. 1B,C). This phenomenon was accompanied by
a signi¢cant visual reduction in O2 consumption and
a drastic reduction in H2O2 accumulation (3100%
for CySH and 360% for GSH) (Fig. 3B,C, Table 1).
As shown in Fig. 1, the presence of Al3 (800 nM)
drastically reduced (391%) the production of cOH
during 6-OHDA (5 WM) autoxidation (Table 1).
This e¡ect was accompanied by both a considerable
reduction in O2 consumption (Fig. 2) and a signi¢-
cant decrease (322%) in H2O2 accumulation during
the autoxidation of 6-OHDA (400 WM) in the pres-
ence of Al3 (64 WM) (Table 1). As illustrated in Fig.
1A, when the autoxidation of 6-OHDA takes place
under the simultaneous presence of AA+Al3, a
marked increase (+257%) in cOH production was
observed (Table 1). At this point it is important to
remark that the slope of the continuous cOH produc-
tion observed after the ¢rst minute of the reaction
with 6-OHDA+Al3+AA (slope = 78.5 þ 0.37, r =
0.998) was signi¢cantly (P6 0.001) higher than that
obtained with 6-OHDA+AA (slope = 29.4 þ 0.40,
r = 0.986), which represents an important increase
Fig. 2. Polarographic monitoring of the e¡ects of the presence
of Al3 on oxygen consumption during 6-OHDA autoxidation
in 25 mM phosphate bu¡er (pH 7.5) in the absence and pres-
ence of: (A) ascorbic acid (AA), (B) L-cysteine (CySH), and (C)
glutathione (GSH). 2000 Wmol/min of CAT were added after
216 s of reaction. Concentrations in the reaction mixture were
as follows: 6-OHDA, 400 WM; Al3, 64 WM; antioxidant,
8 mM.
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in the rate of cOH production. This e¡ect was accom-
panied by a very slight reduction in O2 consumption
but a signi¢cant decrease (319%) in H2O2 accumu-
lation. As shown in Fig. 1B,C, the simultaneous pres-
ence of a sulfhydryl reductant and Al3 also caused a
signi¢cant increase (+66% for CySH and +126% for
GSH) in cOH production during 6-OHDA autoxida-
tion, but in both cases the kinetics maintained its
hyperbolic shape. With regard to the accumulation
of H2O2, a drastic reduction (388% for CySH and
374% for GSH) was observed for both antioxidants
(Fig. 2B,C, Table 1). As illustrated in Fig. 2B,C, this
e¡ect were also accompanied by a signi¢cant reduc-
tion in O2 consumption.
The presence of Zn2 (800 nM) during the autox-
idation of 6-OHDA (5 WM) induced a signi¢cant
reduction in the cOH production (348%), maintain-
ing the shape of the 6-OHDA kinetics (Fig. 3). In
addition, the autoxidation of 6-OHDA (400 WM) in
the presence of Zn2 (64 WM) caused a notable di-
minution in O2 consumption (Fig. 4) and a signi¢-
cant reduction (362%) in H2O2 accumulation (Table
1). The e¡ect achieved with Zn2 in the presence of
AA was a marked increase (+141%) in cOH genera-
tion, which maintained the continuity of the produc-
tion during the autoxidation of 6-OHDA (Fig. 3A).
A signi¢cant (P6 0.01) increase in the rate of cOH
Fig. 3. E¡ects of the presence of Zn2 on cOH formation dur-
ing 6-OHDA autoxidation in the absence and presence of: (A)
ascorbic acid (AA), (B) L-cysteine (CySH), and (C) glutathione
(GSH). Incubations were carried out in 25 mM phosphate bu¡-
er (pH 7.5) at 37‡C. Concentration of reagents was as follows:
6-OHDA, 5 WM; Zn2, 800 nM; antioxidant, 100 WM. cOH
formation is indicated by the detection of £uorescence using
THA as a chemical dosimeter.
Table 1
E¡ects of the presence of Al3 and Zn2 and/or an antioxidant
on the production of cOHa and the formation of H2Ob2 during
6-OHDA autoxidation
Incubation system vFmax(a.u.) H2O2 (nmol)
6-OHDA (control) 78.7 þ 3.21 347 þ 22.8
6-OHDA+AA 135 þ 14.0*** 202 þ 13.4***
6-OHDA+CySH 138 þ 7.25*** N.D.
6-OHDA+GSH 191 þ 5.82*** 139 þ 11.1***
6-OHDA+Al3 6.91 þ 0.33*** 270 þ 9.35**
6-OHDA+Zn2 40.5 þ 2.22*** 131 þ 8.09***
6-OHDA+AA+Al3 281 þ 5.81*** 281 þ 15.1***
6-OHDA+AA+Zn2 190 þ 9.89*** 309 þ 17.3*
6-OHDA+CySH+Al3 131 þ 3.11*** 43.4 þ 2.79***
6-OHDA+CySH+Zn2 142 þ 2.09*** 27.0 þ 5.11***
6-OHDA+GSH+Al3 178 þ 7.23*** 91.5 þ 7.42***
6-OHDA+GSH+Zn2 225 þ 3.71*** 34.0 þ 2.78***
Data are means þ S.E.M. from four determinations. N.D.
means not detected. Statistical signi¢cance: *P6 0.05;
**P6 0.01; ***P6 0.001 (two-sided Student’s t-test).
aIncubations were carried out in 25 mM phosphate bu¡er (pH
7.5) at 37‡C and the concentration of reagents was as follows:
6-OHDA, 5 WM; metal ion, 800 nM; antioxidant, 100 WM.
bIncubations were carried out in 25 mM phosphate bu¡er (pH
7.5) at 25‡C, 2000 Wmol/min CAT were added after 216 s of re-
action, and the concentration of reagents was as follows:
6-OHDA, 400 WM; metal ion, 64 WM; antioxidant, 8 mM.
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production after the ¢rst minute of the reaction
(slope = 43.6 þ 0.26, r = 0.990) was also observed.
The reported e¡ect also involved a slight increase
in O2 consumption and a slight but signi¢cant reduc-
tion (311%) in H2O2 accumulation (Fig. 4A, Table
1). When the antioxidant used was a sulfhydryl sub-
stance, the e¡ect observed with Zn2 was a signi¢-
cant augmentation (+80% for CySH and +186% for
GSH) in cOH production (Fig. 3B,C, Table 1) and a
marked reduction (392% for CySH and 390% for
GSH) in H2O2 accumulation (Fig. 4B,C, Table 1).
As can be seen in Fig. 4B,C, this e¡ect was also
accompanied by a considerable diminution in O2
consumption.
The incubation of 6-OHDA (10 WM) with brain
mitochondria at 37‡C for 10 min induced a signi¢-
cant production of TBARS (Fig. 5), which was
markedly increased (+97%) when the autoxidation
of 6-OHDA took place in the presence of AA (100
WM). As shown in Fig. 5, a signi¢cant reduction
(342%) in TBARS production was observed when
the autoxidation of 6-OHDA occurred in the pres-
ence of Al3 (1.6 WM). However, the observed reduc-
tion was lower (322%) in the presence of AA when
compared with the results obtained with 6-OH-
DA+AA. The presence of Zn2 (1.6 WM) also caused
Fig. 5. In£uence of Al3 and Zn2 in the presence and absence
of ascorbic acid (AA) on TBARS production by 6-OHDA au-
toxidation on mitochondria preparations from rat brain. Mito-
chondria (1 mg protein/ml) were incubated in Na2PO4/KH2PO4
bu¡er isotonized with KCl (pH 7.4) with the corresponding
chemicals for 10 min at 37‡C. Reagent concentrations: 6-
OHDA, 10 WM; Al3 and Zn2, 1.6 WM; AA, 200 WM. Malon-
dialdehyde (MDA) was used to quantify TBARS formation.
Bars represent means þ S.D. from four independent experiments.
Statistical signi¢cance (two-sided Student’s t-test) : aP6 0.05
when compared with Mit+6-OHDA (control) ; bP6 0.05 when
compared with Mit+6-OHDA+AA (control).
Fig. 4. Polarographic monitoring of the e¡ects of the presence
of Zn2 on oxygen consumption during 6-OHDA autoxidation
in 25 mM phosphate bu¡er (pH 7.5) in the absence and pres-
ence of: (A) ascorbic acid (AA), (B) L-cysteine (CySH), and (C)
glutathione (GSH). 2000 Wmol/min of CAT were added after
216 s of reaction. Concentrations in the reaction mixture were
as follows: 6-OHDA, 400 WM; Zn2, 64 WM; antioxidant,
8 mM.
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a signi¢cant diminution (327%) in TBARS forma-
tion during 6-OHDA autoxidation (Fig. 5). How-
ever, when the autoxidation of 6-OHDA occurred
in the presence of AA, Zn2 did not modify signi¢-
cantly the production of TBARS.
In the in vivo experiments, in group A rats, both
right and left striata showed a dense TH immunore-
activity, where only the needle track could be distin-
guished, with no signi¢cant additional lesion. No sig-
ni¢cant di¡erences were observed between the
striatum injected with Al3 alone and the striatum
injected with saline (Fig. 6A). In group B rats both
the right and left striata showed an extensive loss of
TH immunoreactivity (i.e. loss of nigrostriatal dop-
aminergic terminals) around the injection site (Fig.
6B). However, the striatal area of dopaminergic de-
nervation induced by injection of 6-OHDA+Al3
(i.e. right striatum) was statistically signi¢cantly less
than that observed after injection of 6-OHDA+saline
(i.e. left striatum; Fig. 7). It is interesting to remark
that in this study, comparison of lesions on the left
and right striatum of the same rats minimizes the risk
of in£uence of possible additional factors on the re-
sults.
4. Discussion
The results of this study have shown that, under
physiological conditions of pH and temperature, 6-
OHDA su¡ers autoxidation to give H2O2 and cOH.
It is important to point out that the formation of
cOH only occurs within the ¢rst 2 min of the reac-
tion, which appears to demonstrate that this process
is not a consequence of a Fenton-type reaction on
the H2O2 formed. This suggestion is supported by
the fact that the formation of cOH is negligible after
the ¢rst 2 min of the reaction, when the concentra-
Fig. 7. TH-negative area (i.e. complete loss of dopaminergic ter-
minals; mm2) surrounding the injection site in group B rats.
The values obtained from the left striatum (i.e. the side injected
with saline+6-OHDA) were signi¢cantly higher than those ob-
tained from the right striatum (i.e. the side injected with
Al3+6-OHDA). Data are mean þ S.E.M. (n = 5) and the aster-
isk indicates signi¢cant di¡erences (one-way ANOVA followed
by post-hoc Tukey’s test; P6 0.05).
Fig. 6. Microphotographs of tyrosine hydroxylase-immunos-
tained (TH-ir; gray) sections through the striatum of a group
A rat (A) and a group B rat (B). Group A rats (A) were in-
jected with saline into the left striatum (control) and with sal-
ine+Al3 into the right striatum. No signi¢cant lesion was ob-
served surrounding the needle track (arrow). Group B rats (B)
were injected with saline+6-OHDA into the left striatum and
with Al3+6-OHDA into the right striatum. Note a clear loss
(white, asterisks) of TH-ir (i.e. dopaminergic terminals; gray) in
the striatal area surrounding the injection site. Scale bar = 2 mm.
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tion of H2O2 is still considerable. Furthermore, this
fact also seems to demonstrate that the generation of
cOH in the absence of a transition metal occurs
through the involvement of a compound that is
present only at the initiation of 6-OHDA autoxida-
tion. The major candidate to explain this process is
the reaction suggested by Gee and Davison [8] in
which the reduced form of 6-OHDA (QH2) is oxi-
dized by the H2O2 previously formed to give the
semiquinone radical (csQ) and cOH:
QH2 H2O2 ! csQ cOHOH3
Then, csQ may be oxidized by molecular oxygen to
yield the corresponding p-quinone (pQ) and a super-
oxide radical (Oc32 ):
csQO2 ! pQOc32
The presence of AA during 6-OHDA autoxidation
induces a redox cycle, which causes a continuous
production of cOH to AA exhaustion:
Clearly, this fact contributes to interpreting the
suggested role of AA in the neurotoxicity of 6-
OHDA [36]. However, the presence of a sulfhydryl
reductant (CySH or GSH) only induces an increase
in cOH production within the ¢rst 3 min of the re-
action, which precludes the existence of a redox cycle
in the presence of such antioxidants. Evidently, this
observation also agrees with previous work showing
a protective e¡ect of sulfhydryl reductants against
the neurotoxicity of 6-OHDA [36].
The presence of Al3 causes a drastic diminution
in cOH production during 6-OHDA autoxidation,
which is also accompanied by a signi¢cant reduction
in both O2 consumption and H2O2 accumulation.
Taking into account the ¢xed oxidation number of
Al3 and consequently its inability to participate in
redox reactions, the only possible mechanism which
could integrate or explain the results of this study
would be the binding of Al3 to 6-OHDA, an even-
tuality which would hinder the interaction between
6-OHDA and H2O2 :
QH2 Al3 ! QH2WAl3
QH2WAl3 H2O2 ! csQWAl3 or csQAl3
cOHOH3 slow
However, the combined action of Al3 and AA
causes a marked increase in cOH production during
6-OHDA autoxidation, which is accompanied by a
slight augmentation in O2 consumption and a signi¢-
cant reduction in H2O2 accumulation. These ¢ndings
show how the presence of AA not only inhibits the
e¡ect caused by Al3 on cOH production, but also
even signi¢cantly activates the production of cOH
during 6-OHDA autoxidation. Probably, the molec-
ular mechanism implicated in this process might in-
volve a catalytic e¡ect of Al3 on the interaction
between AA and 6-OHDA or the p-quinone. Con-
sidering that the concentration of AA in brain tissue
is in the mM order [45] and that oxidative stress has
been shown to facilitate the accumulation of Al3 in
rat brain synaptosomes [46], this e¡ect would explain
some stressor properties reported for this metal
[20,47]. However, the combined action of Al3 and
a sulfhydryl reductant (CySH or GSH) only exhib-
ited a slight reduction in cOH production when com-
pared to the e¡ect induced by such reductants in the
absence of the metal ion. In addition, once again the
formation of cOH only takes place within the ¢rst 3
min of the reaction. Clearly, Al3 does not contrib-
ute greatly to the oxidative stress induced by 6-
OHDA when this process occurs in the presence of
a sulfhydryl reductant such as CySH and GSH. Evi-
dently, this fact appears to support a neuroprotective
function for sulfhydryl reductants, particularly
CySH, which may explain the reported increase in
the Q-glutamyltranspeptidase activity found in the
substantia nigra of patients su¡ering from PD [48].
Although the reduction induced by the presence of
Al3 on TBARS production by 6-OHDA autoxida-
tion in mitochondria preparations appears to agree
with the diminution observed in cOH formation, the
reduction on TBARS production in the presence of
AA contrasts with the increase observed under these
conditions in cOH formation. Evidently, this fact ap-
pears to agree with the lack of correlation observed
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by other authors [49]. However, assuming that (a)
Al3 can associate to phosphate groups and accumu-
late in membranes due to its low exchange rate [50]
and (b) lipid peroxidation occurs in negatively
charged micelles and not in positively charged mi-
celles [51], the here reported reduction of lipid per-
oxidation in the presence of Al3 appears to be a
consequence of the expected diminution of negative
charge density provoked by the association of this
metal ion to membranes. Evidently, our ¢ndings con-
trast with the reported increase in Fe2-induced lipid
peroxidation by Al3 [52,53], a fact that might be
related to a potential interaction between Fe2 and
Al3 and not to an increase in the rate of propaga-
tion of lipid peroxidation caused by alterations of
lipid packing in membrane. Although Al3 is an
acidic metal that at physiological pH seems to be
in the form of poly-hydrated hydroxides [54]:
Al3aq H2O1AlOH2aq H
Ka  1:12U1035
the presence of the negatively charged phospholipids
of the membrane together with the high capacity
shown by the phosphate group to bind Al3 [55]
will shift this hydrolysis equilibrium to the left, as
it has been previously suggested by Verstraeten et
al. [56].
Stereotaxic injection of 6-OHDA into the medial
forebrain bundle or substantia nigra has been used
for years to produce a rodent model of PD. Dopa-
minergic axons and neuron bodies are densely
packed within these structures, and this injection
originates a complete, or almost complete, destruc-
tion of the nigral dopaminergic neurons and their
terminals in the striatum, producing a model for
the end stage of PD [5]. However, this model has
limited utility for research on neuroprotection or
neurotoxicity in the nigrostriatal system. More re-
cently, a partial lesion model has been developed,
which is particularly useful for research on neuro-
protection and neurotoxicity in PD [6,7]. In this
model a small volume of 6-OHDA is injected into
the striatum, which is a much larger structure, and
selectively eliminates the dopaminergic axons and
terminals within a circumscribed area surrounding
the injection site, followed by a degeneration of the
parent nigral neurons. Intrastriatal injection of 6-
OHDA causes rapid degeneration of nigrostriatal
terminals within as early as 24 h, and the loss of
TH immunoreactivity increases for up to 5 days fol-
lowing the lesion [57]. In the present in vivo study,
the quanti¢cation of the lesion a week after 6-OHDA
injections re£ects, therefore, the long-term damage of
the dopaminergic terminals [8]. In the present work
we have made an immunohistochemical study of the
lesion induced in the striatal dopaminergic terminals
after injection of 6-OHDA, 6-OHDA+Al3, Al3
alone, or saline alone. The results obtained in this
study showed reduction in the nigrostriatal 6-
OHDA-induced lesion in the presence of Al3, as
well as a lack of signi¢cant striatal lesion after in-
jection of Al3 alone, which agrees with the reported
protection of Al3 against the lipid peroxidation in-
duced by 6-OHDA on mitochondria preparations
from rat brain.
The presence of Zn2 causes a signi¢cant reduc-
tion in the production of cOH during 6-OHDA au-
toxidation, which was also accompanied by an im-
portant reduction in both O2 consumption and H2O2
accumulation. Although the e¡ects caused by this
metal ion are less important in relation to those
achieved with Al3, the observed behavior was very
similar, which agrees with the fact that Zn2 is an-
other non-redox cation. At this point, it is important
to note that a light inhibition of dopamine autoxida-
tion in the presence of Zn2 was previously reported
by other authors [58]. Once again, the combined ac-
tion of AA and Zn2 also induced a signi¢cant in-
crease in cOH production, which was greater than
that induced by AA in the absence of zinc. Thus,
although Zn2 might act as an antioxidant prevent-
ing the formation of cOH during 6-OHDA autoxida-
tion, the guaranteed presence of a relatively high
concentration of AA in the brain [45] may contribute
to enhance the oxidative stress caused by 6-OHDA.
Furthermore, this phenomenon is reinforced by the
reported mobilization of Zn2 from metallothionein
under conditions of oxidative stress [59]. Obviously,
the reported ability of Zn2 to increase the produc-
tion cOH by 6-OHDA in the presence of AA is par-
ticularly negative in relation to the development of
PD because an increase in the brain levels of this
metal has been reported in patients su¡ering this
disorder [60].
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Once again, although the reported reduction ex-
hibited by the presence of Zn2 on TBARS forma-
tion by 6-OHDA autoxidation on mitochondria
preparations agrees with the diminution observed in
cOH production, it contrasts with the nonsigni¢cant
e¡ect observed in TBARS production in the presence
of AA which was accompanied by an increase in cOH
production. The explanation of these ¢ndings may be
the same as those given for Al3, but in this case the
protection of Zn2 against lipid peroxidation is not
so important as that observed with the presence of
Al3, which perhaps may be related to the fact that
Zn2 is a divalent ion with a charge density (z/
r = 2.74) lower than that of Al3 (z/r = 5.56).
In summary, it is important to note that the data
reported here show for the ¢rst time how Al3 in the
presence of AA contributes to enhance the produc-
tion of cOH by the autoxidation of 6-OHDA, but
also reduces the lipid peroxidation caused by 6-
OHDA autoxidation in a mitochondria preparation
from rat brain. Furthermore, the presence of Al3 is
able to reduce the extension of the lesions induced by
6-OHDA in the nigrostriatal system of the rat. Thus,
taking into account our results and the suggested
contribution of Al3 accumulation in the brain to
the pathogenesis of PD [16,17,23,24], this latter fact
could be a long-term consequence of the here re-
ported augmentation of cOH production by Al3
during 6-OHDA autoxidation, but not related to
the enhancement of lipid peroxidation, at least in
the absence of high concentrations of free Fe2. Evi-
dently, further investigations will be performed in
order to corroborate this hypothesis. The e¡ects in-
duced by the presence of Zn2 are similar to those
reported by Al3 but much less signi¢cant, which
appears to show that the reported antioxidant prop-
erties of Zn2 might be related to the induction of
Zn2-containing proteins involved in the defence
against oxidative stress. Finally, our results have
also shown that the presence of sulfhydryl reduc-
tants, particularly CySH, might contribute to the re-
duction in the potential oxidative stress caused by
the combined action of 6-OHDA and AA.
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